Prevalence of renal insufficiency in cancer patients: Data from the IRMA-2 study.

@article{Janus2009PrevalenceOR,
  title={Prevalence of renal insufficiency in cancer patients: Data from the IRMA-2 study.},
  author={Nicolas Janus and St{\'e}phane Oudard and Philippe Beuzeboc and Joseph Gligorov and I L Ray-Coquard and Jean François Mor{\`e}re and J P Spano and Xavier Pourrat and Gilbert Deray and Vincent Launay-Vacher},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 15_suppl},
  pages={9559}
}
9559 Background: The IRMA-1 study reported the high prevalence of renal insufficiency (RI) in 4,684 cancer patients, with a glomerular filtration rate (GFR) <90 and <60 ml/min/1.73m2 for 52.9% and 12.0%, respectively. Furthermore, almost 80% of patients were receiving nephrotoxic drugs or drugs necessitating dosage adjustment. The IRMA-2 study was started one year later, in different patients, and consisted of 2 phases: 1) a cross-sectional study, similar to IRMA-1, and 2) a 2-year… CONTINUE READING